ProfileGDS5822 / ILMN_1228808
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 96% 95% 96% 96% 96% 97% 96% 96% 94% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1154596
GSM1276600PDAC Late Ablation Control 21210.295
GSM1276601PDAC Late Ablation Control 31625.196
GSM1276602PDAC Late Ablation 11576.496
GSM1276603PDAC Late Ablation 21622.796
GSM1276604PDAC Late Ablation 32230.397
GSM1303940PDAC Late Ablation_anti-CTLA4 11709.196
GSM1303941PDAC Late Ablation_anti-CTLA4 21778.996
GSM1303942PDAC Late Ablation_anti-CTLA4 31081.294